Active ingredientAniracetamCat. No. P-A162-001CAS 72432-10-1Family · Pharmaceutical analytical standards
Aniracetam
A drug of the racetam family, synthesised in the 1970s, that positively modulates glutamate AMPA receptors; in Italy and Greece it has been prescribed for disorders of cognitive function, for example after a stroke or in dementia. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?In the body it is converted very quickly: about 70 to 80% becomes N-anisoyl-GABA, a metabolite that according to rat studies may contribute to its effects.
Go to the active ingredient →Active ingredientAniracetamCat. No. P-A162-001CAS 72432-10-1
Isotopically labelledAniracetam-13C-d3Cat. No. P-A162-002
ImpurityAniracetam Impurity 1Cat. No. P-A162-003No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.